PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
---|---|---|---|---|---|---|---|
11244446 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | positive | |
if patients with this disease have an hla-matched sibling, then stem cell transplantation should be strongly considered because this is currently the only known curative therapy. | |||||||
11260086 | HLA MATCHED (HLA-MATCHED) | cyclophosphamide | Italian | methotrexate | NA | unclassified | |
NA | |||||||
11260086 | HLA MATCHED (HLA-MATCHED) | cyclophosphamide | Italian | methotrexate | NA | unclassified | |
NA | |||||||
11319586 | NA (NA) | stem cell transplantation | African American | NA | NA | unclassified | |
non-hla barriers to unrelated donor stem cell transplantation. | |||||||
11417475 | HLA IDENTICAL (HLA-IDENTICAL) | etoposide | NA | idarubicin | NA | unclassified | |
NA | |||||||
11535506 | HLA COMPATIBLE (HLA-COMPATIBLE) | stem cell transplantation | NA | NA | NA | unclassified | |
pbsc from hla-compatible unrelated donors can be used safely as an alternative to bm for stem cell transplantation. | |||||||
11571527 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
careful longitudinal studies of the lymphoid cell recovery after stem cell transplantation with other than hla-identical sibling donors illustrated the prolonged t- and b-cellular immunodeficiency post-sct, whereas nk-cell recovery was fast. | |||||||
11704786 | HLA MATCHED (HLA-MATCHED) | cyclophosphamide | NA | methotrexate | NA | unclassified | |
NA | |||||||
11807003 | HLA-A*02 | stem cell transplantation | NA | NA | NA | unclassified | |
the mhag ha-1 forms an immunogenic complex with hla-a2 and induces strong alloimmune responses after stem cell transplantation (sct). | |||||||
11850702 | HLA (HLA) | stem cell transplantation | NA | cyclophosphamide | NA | unclassified | |
in conclusion, haematopoietic stem cell transplantation should be performed early if an hla identical sibling is available. |
Copyright 2024